Boston Scientific (NYSE: BSX) announced today that it completed its previously announced acquisition of SoniVie.

With a market cap of $155.2 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical devices ...

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and ...

A woman who had a spinal cord stimulator implanted in 2020 is suing devicemaker Boston Scientific and the FDA over complications she experienced with the device. Dena Lawler received the Spectra ...

Boston Scientific stock is up as company officials predict that the ongoing trade war won't hinder double-digit sales growth ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

Though Boston Scientific brought in $4.66 billion in revenue for the first quarter of 2025, up 20.9% year over year, the medical devicemaker is bracing for a potential $200 million hit in the second ...

Boston Scientific has reported positive 12-month primary endpoint outcomes from the ADVANTAGE AF trial’s second phase, ...